Parametric Portfolio Associates’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,851
Closed -$1.76M 3652
2021
Q1
$1.76M Sell
14,851
-805
-5% -$95.2K ﹤0.01% 2870
2020
Q4
$1.85M Sell
15,656
-4,400
-22% -$511K ﹤0.01% 2705
2020
Q3
$2.23M Sell
20,056
-12
-0.1% -$1.29K ﹤0.01% 2446
2020
Q2
$2.05M Sell
20,068
-4,910
-20% -$525K ﹤0.01% 2491
2020
Q1
$2.7M Sell
24,978
-11,578
-32% -$1.33M ﹤0.01% 2189
2019
Q4
$4.25M Sell
36,556
-5,189
-12% -$601K ﹤0.01% 2173
2019
Q3
$4.78M Sell
41,745
-2,200
-5% -$219K ﹤0.01% 2052
2019
Q2
$4.19M Sell
43,945
-17,346
-28% -$1.63M ﹤0.01% 2143
2019
Q1
$5.59M Sell
61,291
-5,344
-8% -$437K ﹤0.01% 1911
2018
Q4
$5.06M Buy
66,635
+778
+1% +$57.2K 0.01% 1878
2018
Q3
$5.27M Buy
65,857
+31,433
+91% +$2.93M ﹤0.01% 1987
2018
Q2
$3.42M Sell
34,424
-86,562
-72% -$7.48M ﹤0.01% 2270
2018
Q1
$9.8M Buy
120,986
+2,102
+2% +$170K 0.01% 1351
2017
Q4
$9.36M Buy
+118,884
New +$9.88M 0.01% 1376
2017
Q2
Sell
-92,315
Closed -$9.24M 4073
2017
Q1
$9.24M Buy
92,315
+22,384
+32% +$2.39M 0.01% 1204
2016
Q4
$7.52M Buy
69,931
+67,003
+2,288% +$7.83M 0.01% 1274
2016
Q3
$364K Sell
2,928
-53,959
-95% -$6.37M ﹤0.01% 3330
2016
Q2
$6.05M Buy
56,887
+22,534
+66% +$2.62M 0.01% 1349
2016
Q1
$3.93M Buy
+34,353
New +$4.03M 0.01% 1817

Parametric Portfolio Associates's CBPO Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 14,851 shares — an estimated $1.76M sold.

Parametric Portfolio Associates first reported a position in CBPO in Q1 2016 and held it in 19 quarters. The position peaked at $9.8M in Q1 2018. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Parametric Portfolio Associates reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 14,851 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.76M.
  • Parametric Portfolio Associates first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 19 quarters.
  • Parametric Portfolio Associates's China Biologic Products Holdings, Inc. position peaked at $9.8M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.